FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
Thomas E. Bickett(University of Colorado Anschutz Medical Campus), Sana D. Karam(University of Colorado Denver)
Cited by 34
Related Papers
Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors
|Molecular Carcinogenesis|2016|50
Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization
|Oncotarget|2015|34
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
|Nature Communications|2022|26
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
|Journal of Hematology & Oncology|2015|17
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma
|Cancer Cell International|2017|16